A systematic literature review of herpes zoster incidence worldwide

References

• Centers for Disease Control and Prevention. Shingles (herpes zoster) overview. 2018 Accessed 2020 Apr 28. https://www.cdc.gov/shingles/about/index.html
   Google Scholar
• Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory committee on immunization practices centers for disease c, prevention. prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2008;57:1–30. quiz CE32-34.
   PubMedGoogle Scholar
• Drolet M, Brisson M, Levin MJ, Schmader KE, Oxman MN, Johnson RW, Camden S, Mansi JA. A prospective study of the herpes zoster severity of illness. Clin J Pain. 2010;26:656–66.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Volpi A. Severe complications of herpes zoster. Herpes. 2007;14:35–39.
   PubMedGoogle Scholar
• Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748–53. doi:10.1111/j.1525-1497.2005.0150.x.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, Roos LL, De Serres G. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127:305–14. doi:10.1017/S0950268801005921.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92:1806–21. doi:10.1016/j.mayocp.2017.10.009.
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
   PubMedGoogle Scholar
• Varghese L, Standaert B, Olivieri A, Curran D. The temporal impact of aging on the burden of herpes zoster. BMC Geriatr. 2017;17:30. doi:10.1186/s12877-017-0420-9.
   PubMed Web of Science ®Google Scholar
• Higgins JPTG, S. cochrane handbook for systematic reviews of interventions version 5.0.0 (updated february 2008). The Cochrane Collaboration; 2008 Accessed 2020 Sept 11. www.cochrane-handbook.org
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. doi:10.1371/journal.pmed.1000100.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Fleurence RL, Hollenbeak CS. Rates and probabilities in economic modelling: transformation, translation and appropriate application. Pharmacoeconomics. 2007;25:3–6. doi:10.2165/00019053-200725010-00002.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Santibanez TA, Gargiullo P, Guris D. Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep. 2007;122:155–59. doi:10.1177/003335490712200204.
   PubMed Web of Science ®Google Scholar
• Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014;42:325–34. doi:10.1007/s15010-013-0550-8.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159:739–45.
   PubMed Web of Science ®Google Scholar
• Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis. 2015;15:502. doi:10.1186/s12879-015-1262-8.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63:221–26. doi:10.1093/cid/ciw296.
   PubMed Web of Science ®Google Scholar
• Krishnarajah G, Carroll C, Priest J, Arondekar B, Burstin S, Levin M. Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006-2010. Hum Vaccin Immunother. 2014;10:2460–67. doi:10.4161/hv.29303.
   PubMed Web of Science ®Google Scholar
• Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10:e1001420. doi:10.1371/journal.pmed.1001420.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52:332–40. doi:10.1093/cid/ciq077.
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133:245–53. doi:10.1017/S095026880400281X.
   PubMed Web of Science ®Google Scholar
• Suaya JA, Chen SY, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis. 2014;1:ofu049. doi:10.1093/ofid/ofu049.
   PubMedGoogle Scholar
• Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341–49. doi:10.4065/82.11.1341.
   PubMed Web of Science ®Google Scholar
• Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health. 2005;5:68. doi:10.1186/1471-2458-5-68.
   PubMed Web of Science ®Google Scholar
• Harpaz R, Leung JW. The epidemiology of herpes zoster in the united states during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019;69(2):341–344. doi:10.1093/cid/ciy953.
   Web of Science ®Google Scholar
• Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination. Can Commun Dis Rep. 2007;33:1–15.
   PubMedGoogle Scholar
• Marra F, Chong M, Najafzadeh M. Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis. 2016;16:589. doi:10.1186/s12879-016-1898-z.
   PubMed Web of Science ®Google Scholar
• McDonald BM, Dover DC, Simmonds KA, Bell CA, Svenson LW, Russell ML. The effectiveness of shingles vaccine among Albertans aged 50years or older: a retrospective cohort study. Vaccine. 2017;35:6984–89. doi:10.1016/j.vaccine.2017.10.067.
   PubMed Web of Science ®Google Scholar
• Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014;32:6319–24. doi:10.1016/j.vaccine.2013.09.018.
   PubMed Web of Science ®Google Scholar
• Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect. 2007;135:908–13. doi:10.1017/S0950268807007893.
   PubMed Web of Science ®Google Scholar
• Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29:8580–84. doi:10.1016/j.vaccine.2011.09.024.
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Keel P, Mullett D, Correa A, de Lusignan S, Ramsay M. Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health. 2018;3:e82–e90. doi:10.1016/S2468-2667(17)30234-7.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and wales. J Med Virol. 2003;70(Suppl 1):S9–14. doi:10.1002/jmv.10313.
   PubMedGoogle Scholar
• Fleming DM, Bartelds A, Chapman RS, Cross KW. The consistency of shingles and its significance for health monitoring. Eur J Epidemiol. 2004;19:1113–18. doi:10.1007/s10654-004-2219-1.
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137:38–47. doi:10.1017/S0950268808000678.
   PubMed Web of Science ®Google Scholar
• Jain A, van Hoek AJ, Walker JL, Forbes HJ, Langan SM, Root A, Smeeth L, Thomas SL. Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the U.K. Clinical practice research datalink. Br J Dermatol. 2018;178:1324–30. doi:10.1111/bjd.16399.
   PubMed Web of Science ®Google Scholar
• Walker JL, Andrews NJ, Amirthalingam G, Forbes H, Langan SM, Thomas SL. Effectiveness of herpes zoster vaccination in an older United Kingdom population. Vaccine. 2018;36:2371–77. doi:10.1016/j.vaccine.2018.02.021.
   PubMed Web of Science ®Google Scholar
• Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect. 2015;70:178–86. doi:10.1016/j.jinf.2014.08.018.
   PubMed Web of Science ®Google Scholar
• Schiffner-Rohe J, Jow S, Lilie HM, Koster I, Schubert I. [Herpes zoster in Germany. A retrospective analyse of SHL data]. MMW Fortschr Med. 2010;151:193–97.
   PubMedGoogle Scholar
• Schmidt-Ott R, Schutter U, Simon J, Nautrup BP, von Krempelhuber A, Gopala K, Anastassopoulou A, Guignard A, Curran D, Matthews S, et al. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged >/=50 years: A prospective study. J Infect. 2018;76:475–82. doi:10.1016/j.jinf.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Ultsch B, Koster I, Reinhold T, Siedler A, Krause G, Icks A, Schubert I, Wichmann O. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. 2013;14:1015–26. doi:10.1007/s10198-012-0452-1.
   PubMed Web of Science ®Google Scholar
• Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173. doi:10.1186/1471-2334-11-173.
   PubMed Web of Science ®Google Scholar
• Imafuku S, Matsuki T, Mizukami A, Goto Y, de Souza S, Jegou C, Bianco V, Rosillon D, Ito C, Curran D, et al. Burden of herpes zoster in the Japanese population with immunocompromised/chronic disease conditions: results from a cohort study claims database from 2005-2014. Dermatol Ther (Heidelb). 2019;9(1):117–133. doi:10.1007/s13555-018-0268-8.
   Web of Science ®Google Scholar
• Shiraki K, Toyama N, Daikoku T, Yajima M. Herpes zoster and recurrent herpes zoster. Open Forum Infect Dis. 2017;4:ofx007. doi:10.1093/ofid/ofx007.
   PubMed Web of Science ®Google Scholar
• Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, et al. Incidences of herpes zoster and postherpetic neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: the SHEZ study. J Epidemiol. 2015;25:617–25.
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K. Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture. J Med Virol. 2009;81:2053–58.
   PubMed Web of Science ®Google Scholar
• Toyama N, Shiraki K. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect. J Dermatol Sci. 2018;92:89–96. doi:10.1016/j.jdermsci.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract. 2002;19:471–75. doi:10.1093/fampra/19.5.471.
   PubMed Web of Science ®Google Scholar
• Opstelten W, van Essen GA, Moons KG, van Wijck AJ, Schellevis FG, Kalkman CJ, Verheij TJ. Do herpes zoster patients receive antivirals? A dutch national survey in general practice. Fam Pract. 2005;22:523–28. doi:10.1093/fampra/cmi055.
   PubMed Web of Science ®Google Scholar
• Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006;16:692–95. doi:10.1016/j.annepidem.2005.12.002.
   PubMed Web of Science ®Google Scholar
• Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis. 2012;12:110. doi:10.1186/1471-2334-12-110.
   PubMed Web of Science ®Google Scholar
• Cebrian-Cuenca AM, Diez-Domingo J, Rodriguez MS, Puig-Barbera J, Navarro-Perez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract. 2010;11:33.
   PubMed Web of Science ®Google Scholar
• Esteban-Vasallo MD, Gil-Prieto R, Dominguez-Berjon MF, Astray-Mochales J, Gil de Miguel A. Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005-2012. J Infect. 2014;68:378–86. doi:10.1016/j.jinf.2013.09.035.
   PubMed Web of Science ®Google Scholar
• Garcia Cenoz M, Castilla J, Montes Y, Moran J, Salaberri A, Elia F, Floristan Y, Rodrigo I, Irisarri F, Arriazu M, et al. [Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006]. An Sist Sanit Navar. 2008;31:71–80.
   PubMed Web of Science ®Google Scholar
• Morant-Talamante N, Diez-Domingo J, Martinez-Ubeda S, Puig-Barbera J, Aleman-Sanchez S, Perez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis. 2013;13:463. doi:10.1186/1471-2334-13-463.
   PubMed Web of Science ®Google Scholar
• Munoz-Quiles C, Lopez-Lacort M, Ampudia-Blasco FJ, Diez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009-2014. Hum Vaccin Immunother. 2017;13:2606–11. doi:10.1080/21645515.2017.1368600.
   PubMed Web of Science ®Google Scholar
• Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect. 2012;140:1131–40. doi:10.1017/S0950268811001786.
   PubMed Web of Science ®Google Scholar
• Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, Chen CC, Lee DD, Chang YT, Wang WJ, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009;89:612–16. doi:10.2340/00015555-0729.
   PubMed Web of Science ®Google Scholar
• Lin YH, Huang LM, Chang IS, Tsai FY, Lu CY, Shao PL, Chang LY. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine. 2010;28:1217–20. doi:10.1016/j.vaccine.2009.11.029.
   PubMed Web of Science ®Google Scholar
• Lu WH, Lin CW, Wang CY, Chen LK, Hsiao FY. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. BMC Public Health. 2018;18:369. doi:10.1186/s12889-018-5247-6.
   PubMed Web of Science ®Google Scholar
• Liu B, Heywood AE, Reekie J, Banks E, Kaldor JM, McIntyre P, Newall AT, Macintyre CR. Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study. Epidemiol Infect. 2015;143:2871–81. doi:10.1017/S0950268814003653.
   PubMed Web of Science ®Google Scholar
• MacIntyre R, Stein A, Harrison C, Britt H, Mahimbo A, Cunningham A. Increasing trends of herpes zoster in Australia. PLoS One. 2015;10:e0125025. doi:10.1371/journal.pone.0125025.
   PubMed Web of Science ®Google Scholar
• Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine. 2009;27:520–29. doi:10.1016/j.vaccine.2008.11.012.
   PubMed Web of Science ®Google Scholar
• Li Y, An Z, Yin D, Liu Y, Huang Z, Xu J, Ma Y, Tu Q, Li Q, Wang H. Disease burden due to herpes zoster among population aged >/=50 years old in China: a community based retrospective survey. PLoS One. 2016;11:e0152660. doi:10.1371/journal.pone.0152660.
   PubMed Web of Science ®Google Scholar
• Lu L, Suo L, Li J, Pang X. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China. Hum Vaccin Immunother. 2018;1–4. doi:10.1080/21645515.2018.1489193.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zheng H, Qu H, Deng H, Zhang J, Ma W, Lin Y, Xie X, Qiu Q, Huang Z. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015;11:2113–18. doi:10.1080/21645515.2015.1016672.
   PubMed Web of Science ®Google Scholar
• Alicino C, Trucchi C, Paganino C, Barberis I, Boccalini S, Martinelli D, Pellizzari B, Bechini A, Orsi A, Bonanni P, et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: results from a 3-years population-based study. Hum Vaccin Immunother. 2017;13:399–404. doi:10.1080/21645515.2017.1264834.
   PubMed Web of Science ®Google Scholar
• Di Legami V, Gianino MM, Ciofi Degli Atti M, Massari M, Migliardi A, Tomba GS, Zotti C. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine. 2007;25:7598–604. doi:10.1016/j.vaccine.2007.07.049.
   PubMed Web of Science ®Google Scholar
• Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, Di Marzo R, Volpi A. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230. doi:10.1186/1471-2334-10-230.
   PubMed Web of Science ®Google Scholar
• Gonzalez Chiappe S, Sarazin M, Turbelin C, Lasserre A, Pelat C, Bonmarin I, Chosidow O, Blanchon T, Hanslik T. Herpes zoster: burden of disease in France. Vaccine. 2010;28:7933–38. doi:10.1016/j.vaccine.2010.09.074.
   PubMed Web of Science ®Google Scholar
• Mick G, Gallais JL, Simon F, Pinchinat S, Bloch K, Beillat M, Serradell L, Derrough T. [Burden of herpes zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over]. Rev Epidemiol Sante Publique. 2010;58:393–401. doi:10.1016/j.respe.2010.06.166.
   PubMed Web of Science ®Google Scholar
• Reid JS, Ah Wong B. Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years. N Z Med J. 2014;127:56–60.
   PubMedGoogle Scholar
• Turner NM, MacRae J, Nowlan ML, McBain L, Stubbe MH, Dowell A. Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm. BMJ Open. 2018;8:e021241. doi:10.1136/bmjopen-2017-021241.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Cassel T, Lindquist L. Burden of herpes zoster and post-herpetic neuralgia in Sweden. BMC Infect Dis. 2015;15:215. doi:10.1186/s12879-015-0951-7.
   PubMed Web of Science ®Google Scholar
• Sundstrom K, Weibull CE, Soderberg-Lofdal K, Bergstrom T, Sparen P, Arnheim-Dahlstrom L. Incidence of herpes zoster and associated events including stroke–a population-based cohort study. BMC Infect Dis. 2015;15:488. doi:10.1186/s12879-015-1170-y.
   PubMed Web of Science ®Google Scholar
• Schmidt SAJ, Vestergaard M, Baggesen LM, Pedersen L, Schonheyder HC, Sorensen HT. Prevaccination epidemiology of herpes zoster in Denmark: quantification of occurrence and risk factors. Vaccine. 2017;35:5589–96.
   PubMed Web of Science ®Google Scholar
• Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of Herpes Zoster and its complications. J Infect. 2013;67:463–69. doi:10.1016/j.jinf.2013.06.016.
   PubMed Web of Science ®Google Scholar
• Rimseliene G, Vainio K, Gibory M, Salamanca BV, Flem E. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway. BMC Infect Dis. 2016;16:254. doi:10.1186/s12879-016-1581-4.
   PubMed Web of Science ®Google Scholar
• Albrecht P, Patrzalek M, Gorynski P. The burden of Herpes Zoster and its complications in Poland in according to the age. Przegl Epidemiol. 2015;69:841–693.
   Google Scholar
• Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in Korea. J Korean Med Sci. 2014;29:1706–10. doi:10.3346/jkms.2014.29.12.1706.
   PubMed Web of Science ®Google Scholar